ERBB2 and prostate cancer: For instance, estrogen biosynthesis, estrogen receptors, and HER2 are relevant in breast cancer (Ventura et al., 2025; Yan et al., 2024), while androgen receptors are significant in prostate cancer (Danielli et al., 2025).